6533b82afe1ef96bd128c012
RESEARCH PRODUCT
CXCR4 and hif-1α as prognostic molecular markers for stage 3 colon cancer patients: post hoc analysis of the randomized, multicenter phase 3 PETACC-2 trial dataset
Christiane GogMurielle MauerMarkus MoehlerC. KoehneDaniela E. AustArndt WeinmannManfred P. LutzThomas SchmittErik TanisThomas ThomaidisFelicitas RoelofsonFrederic FiteniAnnett Maderersubject
Oncologymedicine.medical_specialtyColorectal cancerbusiness.industrymedicine.medical_treatmentMEDLINEHematologyGeneral MedicineDiseasemedicine.diseaseCXCR4OncologyInternal medicinePost-hoc analysismedicineRadiology Nuclear Medicine and imagingStage (cooking)businessAdjuvantdescription
Adjuvant colon cancer (CC) therapy and survival have greatly evolved over the last decades. Research shifted towards a more biological tumour understanding and unlocked new therapies and disease mo...
year | journal | country | edition | language |
---|---|---|---|---|
2021-08-06 | Acta Oncologica |